FDA 483 - Ningxia Qiyuan Pharmaceutical Co., Ltd. - September 12, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Ningxia Qiyuan Pharmaceutical Co., Ltd. in Yinchuan, China, an API manufacturer, revealed significant deficiencies in their equipment cleaning procedures. The firm's cleaning protocols lacked sufficient detail, failing to establish critical parameters like maximum time between processing and cleaning, clean hold times, and methods to prevent contamination. These issues raise concerns about the reproducibility and effectiveness of their cleaning processes for API manufacturing.
ID · 27882229-6689-4914-b065-11615aa88d35